BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 19821721)

  • 1. Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon.
    Barakat FM; McDonald V; Foster GR; Tovey MG; Korbel DS
    J Infect Dis; 2009 Nov; 200(10):1548-55. PubMed ID: 19821721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of interferon-gamma-mediated signalling pathway in intestinal epithelial cells by Cryptosporidium parvum infection.
    Choudhry N; Korbel DS; Edwards LA; Bajaj-Elliott M; McDonald V
    Cell Microbiol; 2009 Sep; 11(9):1354-64. PubMed ID: 19473199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection.
    Aguirre SA; Perryman LE; Davis WC; McGuire TC
    J Immunol; 1998 Aug; 161(4):1891-900. PubMed ID: 9712058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
    Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
    Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection.
    Lacroix S; Mancassola R; Naciri M; Laurent F
    Infect Immun; 2001 Mar; 69(3):1635-42. PubMed ID: 11179338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum.
    Urban JF; Fayer R; Chen SJ; Gause WC; Gately MK; Finkelman FD
    J Immunol; 1996 Jan; 156(1):263-8. PubMed ID: 8598471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against the early acute phase of Cryptosporidium parvum infection conferred by interleukin-4-induced expression of T helper 1 cytokines.
    McDonald SA; O'Grady JE; Bajaj-Elliott M; Notley CA; Alexander J; Brombacher F; McDonald V
    J Infect Dis; 2004 Sep; 190(5):1019-25. PubMed ID: 15295711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protective role for interleukin 18 in interferon γ-mediated innate immunity to Cryptosporidium parvum that is independent of natural killer cells.
    Choudhry N; Petry F; van Rooijen N; McDonald V
    J Infect Dis; 2012 Jul; 206(1):117-24. PubMed ID: 22517912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune responses against Cryptosporidium parvum infection.
    McDonald V; Korbel DS; Barakat FM; Choudhry N; Petry F
    Parasite Immunol; 2013 Feb; 35(2):55-64. PubMed ID: 23173616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune response in IL-12 and IFN-gamma deficient mice after infection with Cryptosporidium parvum.
    Jakobi V; Petry F
    Parasite Immunol; 2008 Mar; 30(3):151-61. PubMed ID: 18179628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum.
    Pollok RC; Farthing MJ; Bajaj-Elliott M; Sanderson IR; McDonald V
    Gastroenterology; 2001 Jan; 120(1):99-107. PubMed ID: 11208718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency.
    Kuhls TL; Mosier DA; Abrams VL; Crawford DL; Greenfield RA
    J Parasitol; 1994 Jun; 80(3):480-5. PubMed ID: 7515109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma is required for innate immunity to Cryptosporidium parvum in mice.
    Hayward AR; Chmura K; Cosyns M
    J Infect Dis; 2000 Sep; 182(3):1001-4. PubMed ID: 10950807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor necrosis factor alpha in development of immunity against Cryptosporidium parvum infection.
    Lean IS; Lacroix-Lamandé S; Laurent F; McDonald V
    Infect Immun; 2006 Jul; 74(7):4379-82. PubMed ID: 16790816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma-mediated activation of enterocytes in immunological control of Encephalitozoon intestinalis infection.
    Choudhry N; Korbel DS; Zaalouk TK; Blanshard C; Bajaj-Elliott M; McDonald V
    Parasite Immunol; 2009 Jan; 31(1):2-9. PubMed ID: 19121078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection.
    Robinson P; Okhuysen PC; Chappell CL; Lewis DE; Shahab I; Lahoti S; White AC
    Cytokine; 2001 Jul; 15(1):39-46. PubMed ID: 11509007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and activation of human and mouse complement by Cryptosporidium parvum (Apicomplexa) and susceptibility of C1q- and MBL-deficient mice to infection.
    Petry F; Jakobi V; Wagner S; Tessema TS; Thiel S; Loos M
    Mol Immunol; 2008 Jul; 45(12):3392-400. PubMed ID: 18501966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host immune response to Cryptosporidium parvum infection.
    Petry F; Jakobi V; Tessema TS
    Exp Parasitol; 2010 Nov; 126(3):304-9. PubMed ID: 20685209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion.
    White AC; Robinson P; Okhuysen PC; Lewis DE; Shahab I; Lahoti S; DuPont HL; Chappell CL
    J Infect Dis; 2000 Feb; 181(2):701-9. PubMed ID: 10669358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.